Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.03
(0.0%)
CNY 8.03
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.89 Billion CNY | 10.1% |
| 2022 | 1.71 Billion CNY | 29.99% |
| 2021 | 1.32 Billion CNY | 9.58% |
| 2020 | 1.2 Billion CNY | 23.12% |
| 2019 | 980.24 Million CNY | 20.13% |
| 2018 | 815.98 Million CNY | 21.25% |
| 2017 | 672.98 Million CNY | 84.75% |
| 2016 | 364.27 Million CNY | 5.24% |
| 2015 | 346.13 Million CNY | 4.98% |
| 2014 | 329.71 Million CNY | -1.23% |
| 2013 | 333.83 Million CNY | -6.78% |
| 2012 | 358.12 Million CNY | 21.12% |
| 2011 | 295.68 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.87 Billion CNY | -0.82% |
| 2024 Q3 | 1.81 Billion CNY | 1.13% |
| 2024 Q2 | 1.79 Billion CNY | -4.28% |
| 2023 Q4 | 1.89 Billion CNY | 3.21% |
| 2023 FY | 1.89 Billion CNY | 10.1% |
| 2023 Q3 | 1.83 Billion CNY | 2.39% |
| 2023 Q1 | 1.81 Billion CNY | 5.62% |
| 2023 Q2 | 1.79 Billion CNY | -1.35% |
| 2022 Q4 | 1.71 Billion CNY | 7.67% |
| 2022 Q1 | 1.38 Billion CNY | 4.77% |
| 2022 Q2 | 1.53 Billion CNY | 10.92% |
| 2022 FY | 1.71 Billion CNY | 29.99% |
| 2022 Q3 | 1.59 Billion CNY | 3.89% |
| 2021 Q3 | 1.24 Billion CNY | 0.29% |
| 2021 FY | 1.32 Billion CNY | 9.58% |
| 2021 Q1 | 1.22 Billion CNY | 1.7% |
| 2021 Q2 | 1.23 Billion CNY | 0.83% |
| 2021 Q4 | 1.32 Billion CNY | 6.54% |
| 2020 FY | 1.2 Billion CNY | 23.12% |
| 2020 Q1 | 976.72 Million CNY | -0.36% |
| 2020 Q2 | 1.22 Billion CNY | 25.75% |
| 2020 Q3 | 1.22 Billion CNY | -0.5% |
| 2020 Q4 | 1.2 Billion CNY | -1.24% |
| 2019 FY | 980.24 Million CNY | 20.13% |
| 2019 Q2 | 872.87 Million CNY | 5.78% |
| 2019 Q1 | 825.14 Million CNY | 1.12% |
| 2019 Q3 | 937.31 Million CNY | 7.38% |
| 2019 Q4 | 980.24 Million CNY | 4.58% |
| 2018 Q1 | 704.05 Million CNY | 4.62% |
| 2018 FY | 815.98 Million CNY | 21.25% |
| 2018 Q4 | 815.98 Million CNY | 8.03% |
| 2018 Q3 | 755.31 Million CNY | 6.06% |
| 2018 Q2 | 712.12 Million CNY | 1.15% |
| 2017 Q3 | 629.37 Million CNY | 3.14% |
| 2017 FY | 672.98 Million CNY | 84.75% |
| 2017 Q4 | 672.98 Million CNY | 6.93% |
| 2017 Q1 | 637.19 Million CNY | 74.92% |
| 2017 Q2 | 610.2 Million CNY | -4.24% |
| 2016 Q2 | 329.89 Million CNY | 0.0% |
| 2016 FY | 364.27 Million CNY | 5.24% |
| 2016 Q4 | 364.27 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2015 FY | 346.13 Million CNY | 4.98% |
| 2014 Q1 | 344.81 Million CNY | 0.0% |
| 2014 Q2 | 344.81 Million CNY | 0.0% |
| 2014 Q4 | 329.71 Million CNY | 0.0% |
| 2014 FY | 329.71 Million CNY | -1.23% |
| 2013 FY | 333.83 Million CNY | -6.78% |
| 2012 FY | 358.12 Million CNY | 21.12% |
| 2011 FY | 295.68 Million CNY | 0.0% |